Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder

Sahin S., Yuce M., Alacam H., Karabekiroglu K., SAY G. N., Salis O.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, cilt.18, sa.4, ss.280-287, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.3109/13651501.2014.940054
  • Dergi Adı: INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.280-287
  • Anahtar Kelimeler: Attention deficit hyperactivity disorder, methylphenidate, leptin, ghrelin, adiponectin, brain-derived neurotrophic factor, SCHOOL-AGE-CHILDREN, DEFICIT/HYPERACTIVITY DISORDER, RELEASE METHYLPHENIDATE, OROS METHYLPHENIDATE, KOREAN CHILDREN, WEIGHT, HEIGHT, GROWTH, STIMULANTS, EFFICACY
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Objectives. We aimed to explore whether the use of methylphenidate relates leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor (BDNF). In addition, the relationship between methylphenidate-related weight loss in attention deficit hyperactivity disorder (ADHD) patients and these biomolecules were evaluated. Methods. Thirty ADHD patients receiving methylphenidate and 20 healthy controls were included. Leptin, ghrelin, adiponectin, and BDNF levels were measured at baseline and aft er two-month treatment in both groups. Results. At baseline, leptin, ghrelin, adiponectin, and BDNF levels were similar in the ADHD and control groups. The most common adverse events occurring in the ADHD group aft er a 2-month treatment period included loss of appetite (70%) and weight loss (66.7%). A significant difference was found in body weight, BMI, and CGI scores of the ADHD patients aft er the treatment. While post-treatment ghrelin and adiponectin levels were significantly higher in the ADHD group, BDNF level was significantly lower. Post-treatment decrease in leptin levels was not significant. Conclusions. Leptin and BDNF were not associated with poor appetite and/or weight loss due to methylphenidate treatment. However, ghrelin and adiponectin might be biomolecules that play a role in underlying neurobiological mechanisms of methylphenidate-related appetite or weight loss.